Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorders or metabolic bone diseases

Clinical Chemistry

Volumn 42, Issue 11, 1996, Pages 1796-1804

  Woitge, Henning W ^a   Seibel, Markus J ^a   Ziegler, Reinhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

hyperparathyroidism; isoenzymes; liver disease; ROC curve analysis

Indexed keywords

ALKALINE PHOSPHATASE; ISOENZYME;

ADULT; AGED; ARTICLE; BONE DISEASE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LIVER DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERPARATHYROIDISM; RECEIVER OPERATING CHARACTERISTIC;

EID: 0029845152     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.11.1796     Document Type: Article

References (25)

1. Farley JR, Baylink DJ. Skeletal alkaline phosphatase activity as a bone formation index in vitro. Metabolism 1986;35:536-71.
2. Van Straalen JP, Sanders E, Prummel MF, Santers GTB. Bone alkaline phosphatase as indicator of bone formation. Clin Chim Acta 1991;201:27-34.
3. Braga V, Dorizzi R, Brocco G, Rossini M, Zamberlan N, Gatti D, Adami S. Clinical utility of a wheat-germ precipitation assay for the determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases. Eur J Clin Chem Clin Biochem 1995;33:433-9.
4. Weiss MJ, Henthorn PS, Lafferty MA, Slaughter C, Raducha M, Harris H. Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc Natl Acad Sci U S A 1986;83:7182-6.
5. Harris H. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta 1989;186:133-50.
6. Fishman WH. Alkaline phosphatase isoenzymes: recent progress [Review]. Clin Biochem 1990;23:99-104.
7. Moss DW. Perspectives in alkaline phosphatase research [Review]. Clin Chem 1992;38:2386-92.
8. Moss DW, Whitby LG. A simplified heat-inactivation method for investigating alkaline phosphatase isoenzymes in serum. Clin Chim Acta 1975;61:63-71,
9. Behr W, Barnert J. Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin Chem 1986;32:1960-6.
10. Rosalki SB, Foo AY, Burlina A, Prellwitz W, Stieber P, Neumeier D, et al. Multicenter evaluation of iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma. Clin Chem 1993;39:648-52.
11. Van Hoof VO, Lepoutre LG, Hoylaerts MF, Chevigne R, DeBroe ME. Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin Chem 1988;34:1857-62.
12. Farley J, Baylink DJ. Skeletal alkaline phosphatase activity in serum [Editorial]. Clin Chem 1995;41:1551-3.
13. Garnero P, Delmas PD. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993;77:1046-53.
14. Gomez B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 1995;41: 1560-6.
15. "Optimierte Standardmethode" der Deutschen Gesellschaft für Klinische Chemie. J Clin Chem Clin Biochem 1972;10:182-92.
16. Hill CS, Wolfert RL. The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin Chim Acta 1989;186: 315-20.
17. Seibel MJ, Woitge HW, Scheidt-Nave C, Leidig-Bruckner G, Duncan A, Nicol P, et al. Urinary hydroxypyridinium crosslinks of collagen in a population-based screening for overt vertebral osteoporosis: results of a pilot study. J Bone Miner Res 1994;9:1433-40.
18. Eastell R, Delmas PD, Hodgson SF, Eriksen EF, Mann KG, Riggs BL. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics and biochemical markers. J Clin Endocrinol Metab 1988;67:741-8.
19. Schiele F, Henny J, Hitz S, PetitClerc C, Gueguen R, Siest G. Total, bone and liver alkaline phosphatases in plasma: biological variation and reference limits. Clin Chem 1983;23:634-41.
20. Kuwana T, Sugita O, Yakata M. Reference limits of bone and liver alkaline phosphatase isoenzymes in the serum of healthy subjects according to age and sex as determined by wheat germ lectin affinity electrophoresis. Clin Chim Acta 1988;173:273-80.
21. Stepan J, Pacovsky V, Horn V, Silinkova-Malkova E, Vokrouhlicka O, Konopasek B, et al. Relationship of the activity of the bone isoenzyme of serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neoplastic bone diseases. Eur J Clin Invest 1978;8:373-7.
22. Duda RJ, O'Brien JF, Katzmann JA, Petersen JM, Mann KG, Riggs BL. Concurrent assays of circulating bone Gla protein and bone alkaline phosphatase: effects of sex, age and metabolic bone disease. J Clin Endocrinol Metab 1988;66:951-7.
23. Cooper EH, Forbes MA, Hancock AK, Parker D, Laurence V. Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases. Biomed Pharmacother 1992;46:31-6.
24. Deftos LJ, Wolfert RL, Hill CS. Bone alkaline phosphatase in Paget's disease. Horm Metab Res 1991;23:559-61.
25. Rossini M, Gatti D, Zamberlan N, Braga V, Dorizzi R, Adami S. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Miner Res 1994;9: 1833-7.